Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Kevin Chih-Yang Huang

26PUBLICATIONS
15CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersInnate immunityMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

Sort by Publication Date:
|Feb 25, 2026
Heterologous prime-boost immunization of AAV-based neoantigen cancer vaccine induces anti-tumor immunity to inhibit tumor growth and relapse.

Chi-Hsien Huang, Jhen-Yu Chen, Hsin-Yu Chang

|Feb 02, 2026
Targeting ENO1 reprograms macrophage polarization to trigger antitumor immunity and improves the therapeutic effect of radiotherapy.

Yu-Sen Lin, Hsin-Yu Chang, Wei-Ze Hong

|Aug 01, 2025
CHK1 inhibition increases the therapeutic response to radiotherapy via antitumor immunity in ARID1A-deficient colorectal cancer.

Jhen-Yu Chen, Tao-Wei Ke, Shu-Fen Chiang

|Apr 21, 2025
Targeting B7-H3 enhances the efficacy of neoantigen-based cancer vaccine in combination with radiotherapy.

Tao-Wei Ke, Chia-Yi Chen, William Tzu-Liang Chen

|May 31, 2024
Neoantigen-augmented iPSC cancer vaccine combined with radiotherapy promotes antitumor immunity in poorly immunogenic cancers.

Kevin Chih-Yang Huang, William Tzu-Liang Chen, Jia-Yi Chen

|May 15, 2024
Colorectal cancer-specific IFNβ delivery overcomes dysfunctional dsRNA-mediated type I interferon signaling to increase the abscopal effect of radiotherapy.

Kevin Chih-Yang Huang, Shu-Fen Chiang, Hsin-Yu Chang

Pageof 5

Frequent Collaborators

18 joint publications

Kun-San Clifford Chao

5 joint publications

Shu-Fen Chiang

4 joint publications

Chih-Yang Huang

2 joint publications

Wei-Ze Hung

1 joint publications

Khan Farheen Badrealam

1 joint publications

Wei-Wen Kuo

1 joint publications

Shih-Chieh Hung

1 joint publications

Chia-Ying Lai

1 joint publications

Hsin-Yu Chang

1 joint publications

Pei-Chun Lin

Frequent Collaborators

18 joint publications

Kun-San Clifford Chao

5 joint publications

Shu-Fen Chiang

4 joint publications

Chih-Yang Huang

2 joint publications

Wei-Ze Hung

Top Related Videos

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on : Feb 24, 2023

4.1K
Reprograming Model of Human Monocyte-derived Macrophages for <em>In-vitro</em> Assays
08:37

Reprograming Model of Human Monocyte-derived Macrophages for <em>In-vitro</em> Assays

Published on : Apr 18, 2025

1.1K
Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on : Sep 30, 2016

13.9K
See more related videos

Top Related Videos

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on : Feb 24, 2023

4.1K
Reprograming Model of Human Monocyte-derived Macrophages for <em>In-vitro</em> Assays
08:37

Reprograming Model of Human Monocyte-derived Macrophages for <em>In-vitro</em> Assays

Published on : Apr 18, 2025

1.1K
Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on : Sep 30, 2016

13.9K
See more related videos